Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q1 2012 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BERKSHIRE HATHAWAY INC DEL CL B | 23 | Q2 2024 | 24.4% |
DANAHER CORPORATION COM | 23 | Q2 2024 | 18.3% |
STAAR SURGICAL CORPORATION | 23 | Q2 2024 | 20.2% |
FORTIVE CORPORATION | 23 | Q2 2024 | 14.3% |
MONSTER BEVERAGE CORPORATION | 23 | Q2 2024 | 17.3% |
APPLE INC | 23 | Q2 2024 | 0.6% |
AMAZON INC COM | 23 | Q2 2024 | 0.5% |
VANGUARD SHORT TERM TREASURY ETF IV | 20 | Q2 2024 | 23.9% |
LINEAGE CELL THERAPEUTICS INC | 20 | Q2 2024 | 4.8% |
AXON ENTERPRISE INC | 19 | Q2 2024 | 5.9% |
View Defender Capital, LLC.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-07-29 |
13F-HR | 2024-05-06 |
13F-HR | 2024-01-23 |
13F-HR | 2023-10-23 |
13F-HR | 2023-07-18 |
13F-HR/A | 2023-05-16 |
13F-HR | 2023-04-27 |
13F-HR | 2023-01-12 |
13F-HR | 2022-10-18 |
13F-HR | 2022-07-26 |
View Defender Capital, LLC.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.